February 25, 2025
February 25, 2025
October 03, 2024
My-Cardia (USA) Inc. is a wholly owned subsidiary of Cardiac Biotech Solutions, Inc. (‘Cardiac Biotech’). The subsidiary supplies devices, software, smartphone apps, IT support, and technical and clinical services to our international distributors and partners.
Cardiac Biotech has been conducting device trial seminars across China to raise awareness of its MyCardia AT device. These trials are part of our efforts to expand into the Chinese market.
Cardiac Biotech has clearance to market US FDA 510K Registration for our products through My-Cardia (USA) Inc. The MyCardia AT device is also in the pre-registration phase with the National Medical Product Administration (NMPA) in China.
Our products are available through authorized distributors in Thailand, Malaysia, Singapore, Indonesia, Hong Kong, Macau, and Canada, further broadening our global reach in cardiac monitoring technology.
© 2020-2025. Cardiac Biotech Solutions, Inc. - All rights reserved. | Designer